Ayman Al-Khadra Selected Research

atorvastatin drug combination amlodipine

5/2013	Reduction in cardiovascular risk using proactive multifactorial intervention versus usual care in younger (< 65 years) and older (≥ 65 years) patients in the CRUCIAL trial.
7/2012	Proactive cardiovascular risk management versus usual care in patients with and without diabetes mellitus: CRUCIAL trial subanalysis.
4/2011	Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayman Al-Khadra Research Topics

Disease

3	Coronary Disease (Coronary Heart Disease) 05/2013 - 04/2011
2	Hypertension (High Blood Pressure) 07/2012 - 04/2011

Drug/Important Bio-Agent (IBA)

3	atorvastatin drug combination amlodipine FDA Link 05/2013 - 04/2011
2	spiropentaneacetic acid (SPAA)IBA 05/2013 - 07/2012
1	CholesterolIBA 04/2011
1	Antihypertensive Agents (Antihypertensives)IBA 04/2011
1	LipidsIBA 04/2011

Therapy/Procedure

1	Therapeutics 04/2011